Skip to main content
Erschienen in: Gynecological Surgery 4/2016

22.10.2016 | Original Article

ESGE survey on tissue power morcellation complications other than leiomyosarcoma

verfasst von: Vasilios Tanos, Hans Brölmann, Rudy Leon De Wilde, Peter O’Donovan, Elina Symeonidou, Rudi Campo

Erschienen in: Gynecological Surgery | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

The exact incidence of power morcellation complications (PMC) is unknown and probably underestimated. Medical literature mainly describes case reports and the vast majority of complications after tissue power morcellation are not reported. ESGE has run a survey among its members about complications emerging after laparoscopic electromechanical morcellation including the risk of leiomyosarcoma (LMS). The reported risk of a sarcoma after myoma or uterus morcellation is low and presented in a separate article. The Central office using the ESGE server and website, activating the ‘Survey Monkey’ programme, sent a request to 3422 ESGE members to answer, anonymously, a structured electronic questionnaire with multiple structured answer options, within 3 months. The doctors responding to the call were automatically given a serial number in an EXCEL spreadsheet, enabling statistical analysis using the SPSS v.18. The probabilities were calculated by using the raw data as reported to each individual question, dividing the number of incidence with surgeon’s lifetime experience in laparoscopic surgery. The electronic questionnaire was answered by 216 (6 %) surgeons. The majority of the respondents used the morcellator for 10 years. The overall probability of direct power morcellator injuries to internal organs is more frequent (0.12 %) than that of morcellator injuries to the abdominal and pelvic wall (0.06 %). The risk of parasitic myoma is estimated 0.08 and 0.16 % for the de novo endometriosis after myoma and adenomyoma morcellation. Furthermore, the vast majority of surgeons have never experienced bladder or ureter, aorta and vessel injuries by using the morcellator, proven by the standard deviation being close to zero. Three surgeons with morcellator experience between 1 and 5 years were involved in an injury that caused permanent damage, 1 nerve, 2 bowel and 1 port-site hernia injury due to the morcellator. According to surgeons’ answers, death has never occurred after power morcellation. Morcellator technical problems found also to be of low probability between 0.12 and 0.3 % as estimated for all endoscopic surgeries in lifetime of 188 surgeons. The average number of times per doctor where the morcellator stacked and stopped working is 2.17 with standard deviation equal to 4.4 and sum of incidents equal to 426 times for all 196 doctors. The most frequent technical problem was morcellator transient stacking and the least frequent was the morcellator stopped working and colpotomy needed to evacuate the tissue out of the abdominal cavity 0.12 % operations. The majority of surgeons 136/188 (72 %) are using reusable morcellator devices and 51 (27 %) are using disposable devices. Moreover, 97/188 (51.6 %) of surgeons are using exclusively, only reusable morcellators; 56/188 (29.8 %) are using both disposable and reusable types of morcellators. The incidence of power morcellation complications is very low reputedly. The ESGE board advises that endoscopic operations must be performed only by doctors who have had an adequate training and knowledge. It is compulsory to know the publications about dangers, contraindications and complications before performing these operations. A complete knowledge of techniques and principles of endoscopic surgery is needed to avoid and minimize complications. A training session prior to morcellator first use might decrease further PMC.
Literatur
1.
Zurück zum Zitat Milad MP (2014) Milad EA laparoscopic morcellator-related complications. J Minim Invasive Gynecol 21(3):486–491CrossRefPubMed Milad MP (2014) Milad EA laparoscopic morcellator-related complications. J Minim Invasive Gynecol 21(3):486–491CrossRefPubMed
2.
Zurück zum Zitat Milad MP (2003) Sokol E laparoscopic morcellator-related injuries. Am J Assoc Gynecol Laparosc 10(3):383–385CrossRef Milad MP (2003) Sokol E laparoscopic morcellator-related injuries. Am J Assoc Gynecol Laparosc 10(3):383–385CrossRef
4.
Zurück zum Zitat Hagemann IS, Hagemann AR, LiVolsi VA, Montone KT, Chu CS (2011) Risk of occult malignancy in morcellated hysterectomy: a case series. Int J Gynecol Pathol 30(5):476–483CrossRefPubMed Hagemann IS, Hagemann AR, LiVolsi VA, Montone KT, Chu CS (2011) Risk of occult malignancy in morcellated hysterectomy: a case series. Int J Gynecol Pathol 30(5):476–483CrossRefPubMed
5.
Zurück zum Zitat Rivard C, Salhadar A, Kenton K (2012) New challenges in detecting, grading, and staging endometrial cancer after uterine morcellation. J Minim Invasive Gynecol 19(3):313–316CrossRefPubMed Rivard C, Salhadar A, Kenton K (2012) New challenges in detecting, grading, and staging endometrial cancer after uterine morcellation. J Minim Invasive Gynecol 19(3):313–316CrossRefPubMed
6.
Zurück zum Zitat Chapron C, Fauconnier A, Goffinet F, Bréart G, Dubuisson JB (2002) Laparoscopic surgery is not inherently dangerous for patients presenting with benign gynaecologic pathology. Results of a meta-analysis. Hum Reprod 17(5):1334–1342CrossRefPubMed Chapron C, Fauconnier A, Goffinet F, Bréart G, Dubuisson JB (2002) Laparoscopic surgery is not inherently dangerous for patients presenting with benign gynaecologic pathology. Results of a meta-analysis. Hum Reprod 17(5):1334–1342CrossRefPubMed
7.
Zurück zum Zitat Wiser A, Holcroft CA, Tulandi T, Abenhaim HA (2013) Abdominal versus laparoscopic hysterectomies for benign diseases: evaluation of morbidity and mortality among 465,798 cases. Gynecol Surg 10(2):117–122 First online: 12 January 2013CrossRef Wiser A, Holcroft CA, Tulandi T, Abenhaim HA (2013) Abdominal versus laparoscopic hysterectomies for benign diseases: evaluation of morbidity and mortality among 465,798 cases. Gynecol Surg 10(2):117–122 First online: 12 January 2013CrossRef
8.
Zurück zum Zitat Jin C, Hu Y, Chen XC, Zheng FY, Lin F, Zhou K, Chen FD, Gu HZ (2009) Laparoscopic versus open myomectomy: a meta-analysis of randomized controlled trials. European Journal of Obstetrics and Gynecology and Reproductive Biology 145(1):14–21CrossRefPubMed Jin C, Hu Y, Chen XC, Zheng FY, Lin F, Zhou K, Chen FD, Gu HZ (2009) Laparoscopic versus open myomectomy: a meta-analysis of randomized controlled trials. European Journal of Obstetrics and Gynecology and Reproductive Biology 145(1):14–21CrossRefPubMed
9.
Zurück zum Zitat Tanos V, Brölmann H, DeWilde RL, O’Donovan P, Campo R (2015) Myoma morcellation and leiomyosarcoma panic. Gynecol Surg 12:17–19CrossRef Tanos V, Brölmann H, DeWilde RL, O’Donovan P, Campo R (2015) Myoma morcellation and leiomyosarcoma panic. Gynecol Surg 12:17–19CrossRef
10.
Zurück zum Zitat Brölmann H, Tanos V, Grimbizis G, Ind T, Philips K, van den Bosch T, Sawalhe S, van den Haak L, Jansen FW, Pijenenborg J, Taran FA, Brucker S, Waiez A, Campo R, O’Donovan P, DeWilde RL (2015) Options on fibroid morcellation: a literature review. J Gynecol Surg 12:3–15CrossRef Brölmann H, Tanos V, Grimbizis G, Ind T, Philips K, van den Bosch T, Sawalhe S, van den Haak L, Jansen FW, Pijenenborg J, Taran FA, Brucker S, Waiez A, Campo R, O’Donovan P, DeWilde RL (2015) Options on fibroid morcellation: a literature review. J Gynecol Surg 12:3–15CrossRef
11.
Zurück zum Zitat Donnez O, Jadoul P, Squifflet J, Donnez J (2009) A series of 3190 laparoscopic hysterectomies for benign disease from 1990 to 2006: evaluation of complications compared with vaginal and abdominal procedures. BJOG 116(4):492–500CrossRefPubMed Donnez O, Jadoul P, Squifflet J, Donnez J (2009) A series of 3190 laparoscopic hysterectomies for benign disease from 1990 to 2006: evaluation of complications compared with vaginal and abdominal procedures. BJOG 116(4):492–500CrossRefPubMed
12.
Zurück zum Zitat Cucinella G, Granese R, Calagna G, Somigliana E (2011) Perino a parasitic myomas after laparoscopic surgery: an emerging complication in the use of morcellator? Description of four cases. Fertil Steril 96(2):e90–e96CrossRefPubMed Cucinella G, Granese R, Calagna G, Somigliana E (2011) Perino a parasitic myomas after laparoscopic surgery: an emerging complication in the use of morcellator? Description of four cases. Fertil Steril 96(2):e90–e96CrossRefPubMed
13.
Zurück zum Zitat Leren V, Langebrekke A, Qvigstad E (2012) Parasitic leiomyomas after laparoscopic surgery with morcellation. Acta Obstet Gynecol Scand 91(10):1233–1236CrossRefPubMed Leren V, Langebrekke A, Qvigstad E (2012) Parasitic leiomyomas after laparoscopic surgery with morcellation. Acta Obstet Gynecol Scand 91(10):1233–1236CrossRefPubMed
14.
Zurück zum Zitat Van der Meulen JF, Pijnenborg J, Boomsma CM, Verberg M, Geomini P, Bongers MY (2015) Parasitic myoma after laparoscopic morcellation: a systematic review of the literature. BJOG. doi:10.1111/1471-0528.13541 PubMed Van der Meulen JF, Pijnenborg J, Boomsma CM, Verberg M, Geomini P, Bongers MY (2015) Parasitic myoma after laparoscopic morcellation: a systematic review of the literature. BJOG. doi:10.​1111/​1471-0528.​13541 PubMed
15.
Zurück zum Zitat Sinha R, Hegde A, Mahajan C, Dubey N, Sundaram M (2008) Laparoscopic myomectomy: do size, number, and location of the myomas form limiting factors for laparoscopic myomectomy? J Minim Invasive Gynecol 15(3):292–300CrossRefPubMed Sinha R, Hegde A, Mahajan C, Dubey N, Sundaram M (2008) Laparoscopic myomectomy: do size, number, and location of the myomas form limiting factors for laparoscopic myomectomy? J Minim Invasive Gynecol 15(3):292–300CrossRefPubMed
16.
Zurück zum Zitat Ordulu Z, Dal CP, Chong WW, Choy KW, Lee C, Muto MG et al (2010) Disseminated peritoneal leiomyomatosis after laparoscopic supracervical hysterectomy with characteristic molecular cytogenetic findings of uterine leiomyoma. Genes Chromosom Cancer 49(12):1152–1160CrossRefPubMedPubMedCentral Ordulu Z, Dal CP, Chong WW, Choy KW, Lee C, Muto MG et al (2010) Disseminated peritoneal leiomyomatosis after laparoscopic supracervical hysterectomy with characteristic molecular cytogenetic findings of uterine leiomyoma. Genes Chromosom Cancer 49(12):1152–1160CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Kunz G, Beil D, Huppert P, Leyendecker G (2000) Structural abnormalities of the uterine wall in women with endometriosis and infertility visualized by vaginal sonography and magnetic resonance imaging. Hum Reprod 15:76–82CrossRefPubMed Kunz G, Beil D, Huppert P, Leyendecker G (2000) Structural abnormalities of the uterine wall in women with endometriosis and infertility visualized by vaginal sonography and magnetic resonance imaging. Hum Reprod 15:76–82CrossRefPubMed
18.
Zurück zum Zitat Cohen SL, Greenberg JA, Wang KC, Srouji SS, Gargiulo AR, Pozner CN et al (2014) Risk of leakage and tissue dissemination with various contained tissue extraction (CTE) techniques: an in vitro pilot study. J Minim Invasive Gynecol 14:10 Cohen SL, Greenberg JA, Wang KC, Srouji SS, Gargiulo AR, Pozner CN et al (2014) Risk of leakage and tissue dissemination with various contained tissue extraction (CTE) techniques: an in vitro pilot study. J Minim Invasive Gynecol 14:10
19.
Zurück zum Zitat Cohen SL, Einarsson JI, Wang KC, Brown D, Boruta D, Scheib SA et al (2014) Contained power morcellation within an insufflated isolation bag. Obstet Gynecol 124(3):491–497CrossRefPubMed Cohen SL, Einarsson JI, Wang KC, Brown D, Boruta D, Scheib SA et al (2014) Contained power morcellation within an insufflated isolation bag. Obstet Gynecol 124(3):491–497CrossRefPubMed
20.
Zurück zum Zitat Einarsson JI, Cohen SL, Fuchs N, Wang KC (2014) In bag morcellation (IBM). J Minim Invasive Gynecol 14:10 Einarsson JI, Cohen SL, Fuchs N, Wang KC (2014) In bag morcellation (IBM). J Minim Invasive Gynecol 14:10
21.
Zurück zum Zitat Favero G (2013) Tips and tricks for successful manual morcellation: a response to “vaginal morcellation: a new strategy for large gynecological malignant tumors extraction. A pilot study. Gynecol Oncol 128(1):151CrossRefPubMed Favero G (2013) Tips and tricks for successful manual morcellation: a response to “vaginal morcellation: a new strategy for large gynecological malignant tumors extraction. A pilot study. Gynecol Oncol 128(1):151CrossRefPubMed
22.
Zurück zum Zitat Wu SD, Lesani OA, Zhao LC, Johnston WK, Wolf JS Jr, Clayman RV et al (2009) A multi-institutional study on the safety and efficacy of specimen morcellation after laparoscopic radical nephrectomy for clinical stage T1 or T2 renal cell carcinoma. J Endourol 23(9):1513–1518CrossRefPubMed Wu SD, Lesani OA, Zhao LC, Johnston WK, Wolf JS Jr, Clayman RV et al (2009) A multi-institutional study on the safety and efficacy of specimen morcellation after laparoscopic radical nephrectomy for clinical stage T1 or T2 renal cell carcinoma. J Endourol 23(9):1513–1518CrossRefPubMed
23.
Zurück zum Zitat Barrett PH, Fentie DD, Taranger LA (1998) Laparoscopic radical nephrectomy with morcellation for renal cell carcinoma: the Saskatoon experience. Urology 52(1):23–28CrossRefPubMed Barrett PH, Fentie DD, Taranger LA (1998) Laparoscopic radical nephrectomy with morcellation for renal cell carcinoma: the Saskatoon experience. Urology 52(1):23–28CrossRefPubMed
24.
Zurück zum Zitat Parekh AR, Moran ME, Newkirk RE, Desai PJ, Calvano CJ (2000) Tissue removal utilizing steiner morcellator within a lapsac: effects of a fluid-filled environment. J Endourol 14(2):185–189CrossRefPubMed Parekh AR, Moran ME, Newkirk RE, Desai PJ, Calvano CJ (2000) Tissue removal utilizing steiner morcellator within a lapsac: effects of a fluid-filled environment. J Endourol 14(2):185–189CrossRefPubMed
25.
Zurück zum Zitat Verdaasdonk EGG, Stassen LPS, Widhiasmara PP, Dankelman J (2009) Requirements for the design and implementation of checklists for surgical processes. Surg Endosc 23:715–726CrossRefPubMed Verdaasdonk EGG, Stassen LPS, Widhiasmara PP, Dankelman J (2009) Requirements for the design and implementation of checklists for surgical processes. Surg Endosc 23:715–726CrossRefPubMed
26.
Zurück zum Zitat Baker GR, Norton P, Flintoft V et al (2004) The Canadian adverse events study: the incidence of adverse events among hospital patients in Canada. CMAJ 170(11):1678–1686CrossRefPubMedPubMedCentral Baker GR, Norton P, Flintoft V et al (2004) The Canadian adverse events study: the incidence of adverse events among hospital patients in Canada. CMAJ 170(11):1678–1686CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Arkenbout EA, van den Haak L, Driessen SR, Thurkow AL, Jansen FW (2014) Assessing basic ‘physiology’of the morcellation process and tissue spread: a time action analysis. J Minim Invasive Gynaecol pii S1553-4650(14):01448–01444. doi:10.1016/j.jmig.2014.10.009 Arkenbout EA, van den Haak L, Driessen SR, Thurkow AL, Jansen FW (2014) Assessing basic ‘physiology’of the morcellation process and tissue spread: a time action analysis. J Minim Invasive Gynaecol pii S1553-4650(14):01448–01444. doi:10.​1016/​j.​jmig.​2014.​10.​009
Metadaten
Titel
ESGE survey on tissue power morcellation complications other than leiomyosarcoma
verfasst von
Vasilios Tanos
Hans Brölmann
Rudy Leon De Wilde
Peter O’Donovan
Elina Symeonidou
Rudi Campo
Publikationsdatum
22.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Gynecological Surgery / Ausgabe 4/2016
Print ISSN: 1613-2076
Elektronische ISSN: 1613-2084
DOI
https://doi.org/10.1007/s10397-016-0987-8

Weitere Artikel der Ausgabe 4/2016

Gynecological Surgery 4/2016 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.